Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis

This publication has 18 references indexed in Scilit:

• Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002
  International Journal of Radiation Oncology*Biology*Physics, 2003
• Stress and Radiation-Induced Activation of Multiple Intracellular Signaling Pathways¹
  Radiation Research, 2003
• Correlation between Expression of EGFR and the Prognosis of Patients with Cervical Carcinoma
  Gynecologic Oncology, 2002
• Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia
  Seminars in Oncology, 2002
• Abnormal Expression of Epidermal Growth Factor Receptor and c-erbB2 in Squamous Cell Carcinoma of the Cervix: Correlation with Human Papillomavirus and Prognosis
  Tumor Biology, 2001
• The Epidermal Growth Factor Receptor and Its Inhibition in Cancer Therapy
  Pharmacology & Therapeutics, 1999
• c-erbB-2 oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix
  Cancer, 1994
• Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix
  Cancer, 1994
• Prognostic value of epidermal growth factor receptor expression in cervical carcinoma.
  Journal of Clinical Pathology, 1993
• Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix
  Gynecologic Oncology, 1989